Old Web
English
Sign In
Acemap
>
Paper
>
Cost-Effectiveness Analysis of Rivaroxaban in Secondary Prevention of ACS in Sweden
Cost-Effectiveness Analysis of Rivaroxaban in Secondary Prevention of ACS in Sweden
2013
N Begum
Ba Van Hout
Sj Thurston
O. Schoeman
Anina Fraschke
Freek W.A. Verheugt
Keywords:
Physical therapy
Cost-effectiveness analysis
Rivaroxaban
Medicine
secondary prevention
Intensive care medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]